Brand profile · Biotechnology Research

Zelira Therapeutics

Zelira Therapeutics is a Biotechnology Research brand in Perth, Western Australia. Publicly held, at zeliratx.com. It holds one address on record, all in Australia. It employs 10 people, on the record. It lists medicinal cannabis and clinical trials among its specialties. One Australian registration (ABN) is a confirmed match. Its latest round on record is Post IPO equity, US$8.6M. It is listed alongside five similar brands, mostly in Pharmaceutical Manufacturing.

Profile live Public Company Founded 2015 1 entity ABN 1 office country US$ 8.6M Post IPO equity
Registry verified · ABR

Key facts

Counted staff
10
self-reported 2–10 band
Founded
2015
11 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
2
Post IPO equity · Mar 2023 · US$ 8.6M
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity
  • ZELIRA THERAPEUTICS LIMITED

    ABN27103782378

    WAHigh confidenceMatched on exact nameABR

Legal entities

Zelira Therapeutics: 1 registry entityZelira Therapeutics is linked to 1 registry entity: ZELIRA THERAPEUTICS LIMITED (ABN 27103782378, candidate).Zelira TherapeuticsZELIRA THERAPEUTICSLIMITEDABN 27103782378Candidate · High confidence
Show as table · Zelira Therapeutics: 1 registry entity
Zelira Therapeutics: 1 registry entity
ZELIRA THERAPEUTICS LIMITEDABN 27103782378
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Zelira Therapeutics Ltd (formerly Zelda Therapeutics) is a leading global therapeutic medicinal cannabis company with access to the world’s largest and fastest growing cannabis markets.

www.zeliratx.com

Specialties

All 6 specialties
  • Medicinal cannabis
  • Clinical Trials
  • Breast cancer
  • Insominia
  • Brain cancer
  • Eczema

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUSt Georges Ter; Perth, Western Australia 6000Primary

Grid intelligence Members

Funding

Last round · 15 March 2023US$ 8.6MPost IPO equity
Rounds2
Round typePost IPO equity · secondary transaction
Amount (USD)8,600,000
Stage rank6
Investors named0
Since last round2 yr 10 mo

Funding

2 funding roundsFunding timeline. Latest round 15 Mar 2023: Post IPO equity, US$ 8.6M.20152026Post IPO equityUS$ 8.6M2 rounds
Show as table · 2 funding rounds
2 funding rounds
Rounds2
Axis2015 to 2026
Post IPO equity · 15 Mar 2023US$ 8.6M

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

The people relation is never requested, so there is nothing here to unlock.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Zelira Therapeutics?

One Western Australia entity on the ABR: ZELIRA THERAPEUTICS LIMITED (ABN 27 103 782 378), high confidence.

How many people work at Zelira Therapeutics?

10 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does Zelira Therapeutics have offices?

One address on record, Australia only. Primary: St Georges Ter, Perth, Western Australia 6000.

Has Zelira Therapeutics raised funding?

Two rounds. Latest 15 March 2023: post IPO equity, US$8,600,000.

What does Zelira Therapeutics list as its specialties?

Six tags on the brand's own list, among them medicinal cannabis and clinical trials.

Which companies are listed alongside Zelira Therapeutics?

4 profiles list Zelira Therapeutics as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. Biotome Pty Ltd and NeuroScientific Biopharmaceuticals Ltd list it back.

What is Zelira Therapeutics's website?